|category||Olamira tablets||Other hangover products|
|Product nature||Rescue liver protection products, with rescue effect, no side
effects||Mostly health care products or food, no real hangover function|
|Product Features||Hangover liver effect is good, the effective proportion of more
than 95% hangover||Most people hang the wine in general|
|Production Process||Exclusive patent protection varieties||The process is simple and rough|
|Working time||Half an hour hangover effect||12-48 hours, hangover slow effect|
|Branding||Loyalty to consumers||Repeat fewer buyers|
Wegmann et al. Reported that treatment with AICA deicacity (1) in
rats with acute and chronic hepatitis due to ethanol resulted in
partial recovery of respiration and glycogen levels, which
stimulated the metabolism of nitrogen, phosphorus, hexahydrate and
significant Detoxification effect, no effect on fat metabolism.
Katsuki et al. Reported that AICA (1) treatment of various liver
damage rats found that their liver enzyme metabolism and tissue
cells were found to be considerably improved.
Due to ethanol ethanethionine (ethanoletnionine) caused by fatty
liver can be inhibited, due to low protein feed caused by liver
ribonucleic acid reduction, and decreased activity of serum
cholinesterase, etc., can also be inhibited.
Improve liver function
Wong iney Hong et al. Reported that glycosyl lactone, lipoic acid
and AICA are effective drugs for improving liver function, but must
be in the metabolic system, a sufficient amount of oxygen and
sediment supply, in order to work, these substances as stimulants
To act with.Orazamide Tablets instructions
[Drug Name] Common nameOrazamide Tablets
English nameOrazamide Tablets
Ingredients This product is the main component of Orazamide,
Chemical name4-amino-5-formamide imidazole orotate dihydrate.
Molecular formulaC9H10N6O5 2H2O
[Properties] This product is film-coated tablets, remove the
coating was white or white.
[Adaptive] for acute and chronic hepatitis, fatty liver and
cirrhosis of the adjuvant therapy.
Relieve symptoms of alcoholic hepatitis.
Dosage oral, a 2, 3 times a day.
One month a course of treatment.
Generally need 2-3 courses, individual patients need 4 courses was
Serious illness, a dose can be increased to 6-8 tablets.
Adverse reactions are occasional gastrointestinal discomfort and
[Taboo] allergy to this product disabled.
[Note] 1, the product traits change, the prohibition of use.
2, please put the child is not easy to get the place.
Pregnant women and lactating women medication pregnant women and
lactating women with caution.
Pediatric medication is not clear.
Old age medication is not clear.
Drug interactions are not yet clear.
[Drug overdose] is not clear.
Pharmacology and Toxicology 1, pharmacologyThis product in the
gastrointestinal fluid is divided into isomeric
4-amino-5-imidazolamide (AICA) and orotic acid (vitamin B13).
AICA is a precursor of purine, and isomeric salts allow AICA to
bind to hepatocyte nucleic acids, prevent necrosis of liver
parenchymal cells and stimulate the regeneration of hepatocytes.
Does not cause imbalance in the metabolism of nucleic acids,
correction of abnormal protein, fat and carbohydrate metabolism.
In the case of acute liver damage to prevent the development of
With a strong anti-fatty liver activity, the use of this product
for diarrhea patients can increase the patient's urine output,
It is clinically proven that it enhances the patient's appetite and
improves the general symptoms and is particularly effective in
improving the serum protein blood, making the jaundice index,
aminotransferase, bromophenolphthalein, musk, zinc Turbidity and
other indicators of rapid improvement.
This product can improve the digestion and absorption of fat, and
contribute to the absorption of vitamin A and K.
2, toxicology40 mice, intraperitoneal administration, according to
the crown method LD50703.0mg / kg, the average confidence
limit591-815mg / kg (P = 0.05).
The rabbits, mice, rats were fed with drugs for 6 months without
significant differences in teratogenic.